Aneurysmal Subarachnoid Hemorrhage
Aneurysmal Subarachnoid Hemorrhage Market

A subarachnoid hemorrhage (SAH) is bleeding in the space between the brain and the surrounding membrane (subarachnoid space), causing a sudden and severe headache. Bleeding that results from the rupture of an abnormal bulge in a blood vessel (aneurysm) in the brain are known as Aneurysmal Subarachnoid Hemorrhage (aSAH). 


Most spontaneous SAHs result from the rupture of intracranial aneurysms; therefore, risk factors for aneurysm formation overlap with risk factors for SAH such as smoking, hypertension, alcohol abuse, genetic risk, and others.


Aneurysmal Subarachnoid Hemorrhage Epidemiological Segmentation 

The Epidemiological Segmentation of Aneurysmal Subarachnoid Hemorrhage in 7MM from 2017 to 2030 is segmented as:- 

  • Incidence of Subarachnoid Hemorrhage (SAH)
  • Diagnosed Incidence of aSAH
  • Age-specific Incidence of aSAH 
  • WFNS Grade-wise segmentation of aSAH
  • Fisher Grade-wise segmentation of aSAH 
  • Clinical Manifestations of aSAH  


Aneurysmal Subarachnoid Hemorrhage Epidemiology 

  • The total incident cases of Aneurysmal Subarachnoid Hemorrhage in 7MM were 53,611 in 2017.
  • The incident population of Aneurysmal Subarachnoid Hemorrhage in Japan in 2017 was 33,277. 


Aneurysmal Subarachnoid Hemorrhage Market

Market Size of aSAH in 7MM in 2017 was USD 155.47 Million  


Aneurysmal Subarachnoid Hemorrhage Market Drivers

  • Strengthening of the molecular basis of SAH
  • New potential targets for therapeutics development


Aneurysmal Subarachnoid Hemorrhage Market Barriers

  • Limited number of upcoming therapies 
  • Lack of clarity in disease understanding
  • Lack of in-depth pathogenesis 
  • Expensive diagnosis procedures


Aneurysmal Subarachnoid Hemorrhage Emerging Drugs

The emerging drugs of the Aneurysmal Subarachnoid Hemorrhage market are 

  • SFX-01
  • Clazosentan
  • GTX-104
  • EG-1962
  • Nicaplant (nicardipine)

And many others. 


Aneurysmal Subarachnoid Hemorrhage Key Players

The key players in the Aneurysmal Subarachnoid Hemorrhage market are

  • Evgen Pharma
  • Idorsia Pharmaceuticals
  • Grace Therapeutics
  • Edge Therapeutics/PDS Biotechnology Corporation
  • BIT Pharma

And many others.